Commonwealth Equity Services
BHVN icon

Commonwealth Equity Services’s Biohaven BHVN Stock Holding History

Commonwealth Equity Services’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,066
Closed -$156K – 4246
2025
Q2 		$156K Sell
11,066
-2,086
-16% -$37.2K ﹤0.01% 3983
2025
Q1 		$316K Sell
13,152
-452
-3% -$15.9K ﹤0.01% 3446
2024
Q4 		$508K Buy
13,604
+189
+1% +$8.82K ﹤0.01% 2932
2024
Q3 		$670K Buy
13,415
+77
+0.6% +$3K ﹤0.01% 2661
2024
Q2 		$463K Buy
13,338
+1,150
+9% +$45.5K ﹤0.01% 2898
2024
Q1 		$667K Buy
12,188
+830
+7% +$41.1K ﹤0.01% 2572
2023
Q4 		$486K Buy
11,358
+2,474
+28% +$76.9K ﹤0.01% 2734
2023
Q3 		$231K Sell
8,884
-13
-0.1% -$270 ﹤0.01% 3257
2023
Q2 		$213K Buy
+8,897
New +$153K ﹤0.01% 3351

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Commonwealth Equity Services's BHVN Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 11,066 shares — an estimated $156K sold.

Commonwealth Equity Services first reported a position in BHVN in Q2 2023 and held it in 9 quarters. The position peaked at $670K in Q3 2024. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,066 Biohaven shares in Q3 2025, an estimated $156K.
  • Commonwealth Equity Services first reported a position in Biohaven in Q2 2023 and held it in 9 quarters.
  • Commonwealth Equity Services's Biohaven position peaked at $670K in Q3 2024.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.